S-1 Filing

Company

Alzamend Neuro, Inc.

Filed

June 3, 2024

Accession Number

0001214659-24-010447

An S-1 is a registration statement filed by a company preparing for its initial public offering (IPO). It discloses the business model, financials, risk factors, and use of proceeds. Learn more about S-1 filings →